Sign up to save your podcasts
Or
Share MedAI Digest
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
MedAI Digest
MedAI Digest episodes
- Oncology: Moving AI Toward Treatment Decisions, Spatial Risk, and Reliable UseOncology AI is moving closer to clinical decisions: estimating treatment benefit, mapping risk, and handling incomplete evidence. This coverage shows why stronger prediction and better care remain separate…10 min
- Pathology: From Predictive Labels to Treatment Evidence and Clinical WorkflowPathology AI is moving beyond classification toward treatment-benefit estimation, selective slide analysis and clinical sign-out support. The central question is what makes these outputs reliable enough to act…9 min
- Public Health & Epidemiology: From Mapping Risk to Testing AI in Real WorkflowsPublic health AI is moving into care, surveillance and research workflows. This coverage exposes the key evidence gap: identifying vulnerability and improving technical performance do not yet establish…9 min
- Inno8: Preclinical Progress Toward Oral Antibody Prophylaxis for Hemophilia ACan a factor VIIIa-mimetic antibody fragment reach the circulation after oral dosing and remain biologically active? Inno8 achieved both in preclinical experiments, combining potent laboratory procoagulant activity with…9 min
- Predicting Surgical Recommendations for Distal Radial Fractures: Promising AI, Local EvidenceCan artificial intelligence anticipate whether a hand surgeon will recommend surgery for a distal radial fracture? In this single-institution feasibility study, a model combining radiographs with patient data…8 min
- Four MRI Subtypes Map Distinct Patterns of Damage in Multiple SclerosisMultimodal MRI identified four patterns of tissue damage in multiple sclerosis, each associated with a different baseline disability profile. However, associations with subsequent progression weakened after adjustment for…8 min
- Cardiology: Richer Signals Bring More Individualized Risk—and a Higher Evidence BarCardiology AI is extracting risk from routine signals and measuring disease beyond familiar categories. The unresolved step is turning those distinctions into better prevention, surveillance, and procedural decisions.10 min
- HPV Vaccine Chatbot Trial in Japan: Better Knowledge, No Significant Change in WillingnessAn AI chatbot improved HPV vaccine literacy among female caregivers in Japan compared with a government leaflet, with a modest advantage persisting at 2 weeks. However, the trial…8 min
- Tumor Blood Vessels Reveal Divergent Prognostic Signals in Colorectal CancerIn colorectal cancer, vessel abundance and vessel identity showed different associations with survival. Among 837 patients, higher overall tumor vessel density was associated with lower CRC-specific mortality, whereas…8 min
- Blood miRNA Signatures in FPIES: Promising Biomarkers, Unproven Diagnostic ReadinessBlood microRNA profiles in children with food protein-induced enterocolitis syndrome (FPIES) revealed reaction-associated changes and candidate diagnostic signatures. The strongest molecular changes appeared four hours after reaction onset,…10 min
About MedAI Digest
From the publisher's feed
Daily AI medical research digest